UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM N-PX
ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number: 811 - 22819
ETFis Series Trust I
(Exact name of registrant as specified in charter)
1540 Broadway, Suite 1610, New York, NY 10036
(Address of principal executive offices) (Zip code)
ETFis Series Trust I
c/o Corporation Service Company
2711 Centerville Road, Suite 400
Wilmington, DE 19808
(Name and address of agent for service)
Registrant's telephone number, including area code: 212-593-4383
Date of fiscal year end: 10/31
Date of reporting period: July 1, 2014 – June 30, 2015
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (§§ 239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 100 F Street, NE, Washington, DC 20549. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.
PROXY VOTING RECORD
FOR PERIOD JULY 1, 2014 TO JUNE 30, 2015
Item 1. Proxy Voting Record.
=================== TUTTLE TACTICAL MANAGEMENT U.S. CORE ETF ====================
There were no matters relating to a portfolio security considered at any shareholder meeting held during the period covered by this report on Form N-PX with respect to which the Fund was entitled to vote.
============= TUTTLE TACTICAL MANAGEMENT MULTI-STRATEGY INCOME ETF ===============
There were no matters relating to a portfolio security considered at any shareholder meeting held during the period covered by this report on Form N-PX with respect to which the Fund was entitled to vote.
================================ INFRACAP MLP ETF ================================
| Issuer of Portfolio Security | Exchange Ticker Symbol | CUSIP # | Shareholder Meeting Date | Summary of Matter Voted On | Who Proposed Matter: Issuer / Shareholder | Whether Fund Cast Vote on Matter | Fund's Vote For or Against Proposal, or Abstain; For or Withhold Regarding Election of Directors | Whether Vote Was For or Against Management |
| Atlas Pipeline Partners, L.P. | APL | 49392103 | 2/20/2015 | Approve Merger Agreement | Issuer | Yes | For | For |
| Atlas Pipeline Partners, L.P. | APL | 49392103 | 2/20/2015 | Advisory Vote on Golden Parachutes | Issuer | Yes | For | For |
| El Paso Pipeline Partners LP | EPB | 283702108 | 11/20/2014 | Approve Merger Agreement | Issuer | Yes | For | For |
| El Paso Pipeline Partners LP | EPB | 283702108 | 11/20/2014 | Adjourn Meeting | Issuer | Yes | For | For |
| Energy Transfer Partners L.P. | ETP | 29273R109 | 11/20/2014 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Energy Transfer Partners L.P. | ETP | 29273R109 | 11/20/2014 | Adjourn Meeting | Issuer | Yes | For | For |
| Kinder Morgan Energy Partners, LP. | KMP | 494550106 | 11/20/2014 | Approve Merger Agreement | Issuer | Yes | For | For |
| Kinder Morgan Energy Partners, LP. | KMP | 494550106 | 11/20/2014 | Adjourn Meeting | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director:James C Day | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director: Julie H Edwards | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director:William L Ford | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director:John W Gibson | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director:Steven J Malcom | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director:Jim W Mogg | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director:Pattye L Moore | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director:Gary D Parker | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director:Eduardo A Rodriguez | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Election of Director:Terry K Spencr | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Ratify Price Waterhouse Coopers LLP | Issuer | Yes | For | For |
| Oneok, Inc. | OKE | 682680202 | 5/20/2015 | Approve Executive Officer's Compensation | Issuer | Yes | For | For |
| Targa Resources Corp. | TRGP | 87612G10 | 2/20/2015 | Approve Merger Agreement | Issuer | Yes | For | For |
| Targa Resources Corp. | TRGP | 87612G10 | 2/20/2015 | Adjourn Meeting | Issuer | Yes | For | For |
==================== BIOSHARES BIOTECHNOLOGY PRODUCTS FUND =====================
| Issuer of Portfolio Security | Exchange Ticker Symbol | CUSIP # | Shareholder Meeting Date | Summary of Matter Voted On | Who Proposed Matter: Issuer / Shareholder | Whether Fund Cast Vote on Matter | Fund's Vote For or Against Proposal, or Abstain; For or Withhold Regarding Election of Directors | Whether Vote Was For or Against Management |
| Acorda Therapeutics, Inc. | ACOR | 00484M106 | 6/9/2015 | Elect Director Barry Greene | Issuer | Yes | For | For |
| Acorda Therapeutics, Inc. | ACOR | 00484M106 | 6/9/2015 | Elect Director Ian Smith | Issuer | Yes | For | For |
| Acorda Therapeutics, Inc. | ACOR | 00484M106 | 6/9/2015 | Approve Omnibus Stock Plan | Issuer | Yes | For | For |
| Acorda Therapeutics, Inc. | ACOR | 00484M106 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Acorda Therapeutics, Inc. | ACOR | 00484M106 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Aegerion Pharmaceuticals, Inc. | AEGR | 00767E102 | 6/25/2015 | Elect Director Sandford D. Smith | Issuer | Yes | For | For |
| Aegerion Pharmaceuticals, Inc. | AEGR | 00767E102 | 6/25/2015 | Elect Director Paul G. Thomas | Issuer | Yes | For | For |
| Aegerion Pharmaceuticals, Inc. | AEGR | 00767E102 | 6/25/2015 | Elect Director Anne VanLent | Issuer | Yes | For | For |
| Aegerion Pharmaceuticals, Inc. | AEGR | 00767E102 | 6/25/2015 | Approve Conversion of Securities | Issuer | Yes | For | For |
| Aegerion Pharmaceuticals, Inc. | AEGR | 00767E102 | 6/25/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director Leonard Bell | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director David R. Brennan | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director M. Michele Burns | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director Christopher J. Coughlin | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director David L. Hallal | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director John T. Mollen | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director R. Douglas Nordby | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director Alvin S. Parven | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director Ann M. Veneman | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Elect Director Andreas Rummelt | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Alexion Pharmaceuticals, Inc. | ALXN | 015351109 | 5/6/2015 | Approval of 2015 Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director David Baltimore | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Frank J. Biondi, Jr. | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Robert A. Bradway | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Francoise de Carbonnel | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Vance D. Coffman | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Robert A. Eckert | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Greg C. Garland | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Rebecca M. Henderson | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Frank C. Herringer | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Tyler Jacks | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Judith C. Pelham | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director R. Sanders Williams | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Elect Director Ronald D. Sugar | Issuer | Yes | For | For |
| Amgen Inc. | AMGN | 031162100 | 5/14/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| AMGN | 031162100 | 5/14/2015 | Amend proxy vote calculation methodology | Shareholder | Yes | Against | For | |
| Anacor Pharmaceuticals, Inc. | ANAC | 032420101 | 6/9/2015 | Elect Director Mark Leschly | Issuer | Yes | For | For |
| Anacor Pharmaceuticals, Inc. | ANAC | 032420101 | 6/9/2015 | Elect Director William J. Rieflin | Issuer | Yes | For | For |
| Anacor Pharmaceuticals, Inc. | ANAC | 032420101 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Anacor Pharmaceuticals, Inc. | ANAC | 032420101 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Elect Director Jack Lief | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Elect Director Dominic P. Behan | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Elect Director Donald D. Belcher | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Elect Director Scott H. Bice | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Elect Director Harry F. Hixson, Jr. | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Elect Director Tina S. Nova | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Elect Director Phillip M. Schneider | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Elect Director Christine A. White | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Elect Director Randall E. Woods | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Amend Qualified Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Arena Pharmaceuticals, Inc. | ARNA | 040047102 | 6/12/2015 | Ratify KPMG LLP as Auditors | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Alexander J. Denner | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Richard C. Muligan | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Brian S. Posner | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Lynn Schek | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Caroline Dorsa | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Robert W. Pangia | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Eric K. Rowinsky | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Stephen A. Sherwin | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Nancy L. Leaming | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director Stelios Pappadopoulos | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Elect Director George A. Scangos | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Ratify Pricewaterhouse Coopers LLP as Auditor | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Approve 2015 Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Biogen Inc. | BIIB | 09062X103 | 6/10/2015 | Amend 2006 Non-Employee Directors's Equity Plan | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director Jean-Jacques Bienaime | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director Michael Grey | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director Elaine J. Heron | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director Pierre Lapaime | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director V. Bryan Lawlis | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director Richard Meier | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director Alan J. Lewis | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director William D. Young | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director Kenneth M. Bate | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Elect Director Dennis J. Slamon | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Amend 2006 Share Incentive Plan | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| BioMarin Pharmaceutical Inc. | BMRN | 09061G101 | 6/9/2015 | Ratify KPMG LLP as Auditors | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Elect Director Robert J. Huggin | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Elect Director Richard W. Barker | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Elect Director Michael W. Bonney | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Elect Director Michael D. Casey | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Elect Director Carrie S. Cox | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Elect Director Michael A. Friedman | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Elect Director Gilla S. Kaplan | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Elect Director James J. Loughlin | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Elect Director Earnest Mario | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Ratify KPMG LLP as Auditors | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Amend 2008 Stock Incentive Plan | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Celgene Corporation | CELG | 151020104 | 6/17/2015 | Amend risk disclosure per U.S. drug price regulation | Shareholder | Yes | Against | For |
| Dyax Corp. | DYAX | 26746E103 | 5/12/2015 | Elect Director Ron Cohen | Issuer | Yes | For | For |
| Dyax Corp. | DYAX | 26746E103 | 5/12/2015 | Elect Director David J. McLachlan | Issuer | Yes | For | For |
| Dyax Corp. | DYAX | 26746E103 | 5/12/2015 | Elect Director Paolo Pucci | Issuer | Yes | For | For |
| Dyax Corp. | DYAX | 26746E103 | 5/12/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Exelixis, Inc. | EXEL | 30161Q104 | 5/27/2015 | Elect Director Charles Cohen | Issuer | Yes | For | For |
| Exelixis, Inc. | EXEL | 30161Q104 | 5/27/2015 | Elect Director George Posto | Issuer | Yes | For | For |
| Exelixis, Inc. | EXEL | 30161Q104 | 5/27/2015 | Elect Director Jack L. Wyszonierski | Issuer | Yes | For | For |
| Exelixis, Inc. | EXEL | 30161Q104 | 5/27/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Exelixis, Inc. | EXEL | 30161Q104 | 5/27/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Elect Director John F. Coogan | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Elect Director Etienne F. Davignon | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Elect Director Carla A. Hills | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Elect Director Kevin E. Lofton | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Elect Director John C. Martin | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Elect Director Nicholas G. Moore | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Elect Director Richard J. Whitley | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Elect Director Gayle E. Wilson | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Elect Director Per Wold-Olsen | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Ammend Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Amend board procedures to permit written consent by shareholders | Shareholder | Yes | Against | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Amend board rules such that Chairman be independent | Shareholder | Yes | Against | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Amend rules to require annual sustainability report | Shareholder | Yes | Against | For |
| Gilead Sciences Inc. | GILD | 375558103 | 5/6/2015 | Amend risk disclosure per U.S. drug price regulation | Shareholder | Yes | Against | For |
| Halozyme Therapeutics, Inc. | HALO | 40637H109 | 5/6/2015 | Elect Director Jean-Pierre Bizzari | Issuer | Yes | For | For |
| Halozyme Therapeutics, Inc. | HALO | 40637H109 | 5/6/2015 | Elect Director Randal J. Kirk | Issuer | Yes | For | For |
| Halozyme Therapeutics, Inc. | HALO | 40637H109 | 5/6/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Halozyme Therapeutics, Inc. | HALO | 40637H109 | 5/6/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Halozyme Therapeutics, Inc. | HALO | 40637H109 | 5/6/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Incyte Corporation | INCY | 45337C102 | 5/22/2015 | Elect Director Julian C. Baker | Issuer | Yes | For | For |
| Incyte Corporation | INCY | 45337C102 | 5/22/2015 | Elect Director Jean-Jacques Bienaime | Issuer | Yes | For | For |
| Incyte Corporation | INCY | 45337C102 | 5/22/2015 | Elect Director Paul A. Brooke | Issuer | Yes | For | For |
| Incyte Corporation | INCY | 45337C102 | 5/22/2015 | Elect Director Paul J. Clancy | Issuer | Yes | For | For |
| Incyte Corporation | INCY | 45337C102 | 5/22/2015 | Elect Director Wendy L. Dixon | Issuer | Yes | For | For |
| Incyte Corporation | INCY | 45337C102 | 5/22/2015 | Elect Director Paul A. Friedman | Issuer | Yes | For | For |
| Incyte Corporation | INCY | 45337C102 | 5/22/2015 | Elect Director Herve Hoppenot | Issuer | Yes | For | For |
| Incyte Corporation | INCY | 45337C102 | 5/22/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Incyte Corporation | INCY | 45337C102 | 5/22/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | |
| For | ||||||||
| Ironwood Pharmaceuticals, Inc. | IRWD | 46333X108 | 6/3/2015 | Elect Director George H. Conrades | Issuer | Yes | For | For |
| Ironwood Pharmaceuticals, Inc. | IRWD | 46333X108 | 6/3/2015 | Elect Director Lawrence S. Olanoff | Issuer | Yes | For | For |
| Ironwood Pharmaceuticals, Inc. | IRWD | 46333X108 | 6/3/2015 | Elect Director Douglas E. Williams | Issuer | Yes | For | For |
| Ironwood Pharmaceuticals, Inc. | IRWD | 46333X108 | 6/3/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Isis Pharmaceuticals, Inc. | ISIS | 464330109 | 6/9/2015 | Elect Director Breaux B. Castleman | Issuer | Yes | For | For |
| Isis Pharmaceuticals, Inc. | ISIS | 464330109 | 6/9/2015 | Elect Director Frederick T. Muto | Issuer | Yes | For | For |
| Isis Pharmaceuticals, Inc. | ISIS | 464330109 | 6/9/2015 | Amend 2011 Equity Incentive Plan | Issuer | Yes | For | For |
| Isis Pharmaceuticals, Inc. | ISIS | 464330109 | 6/9/2015 | Amend 2002 Non-Employee Directors's Equity Plan | Issuer | Yes | For | For |
| Isis Pharmaceuticals, Inc. | ISIS | 464330109 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Isis Pharmaceuticals, Inc. | ISIS | 464330109 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Keryx Biopharmaceuticals Inc. | KERX | 492515101 | 6/9/2015 | Elect Director Kevin J. Cameron | Issuer | Yes | For | For |
| Keryx Biopharmaceuticals Inc. | KERX | 492515101 | 6/9/2015 | Elect Director Joseph M. Feczko | Issuer | Yes | For | For |
| Keryx Biopharmaceuticals Inc. | KERX | 492515101 | 6/9/2015 | Elect Director Wyche Fowler, Jr. | Issuer | Yes | For | For |
| Keryx Biopharmaceuticals Inc. | KERX | 492515101 | 6/9/2015 | Elect Director Jack Kaye | Issuer | Yes | For | For |
| Keryx Biopharmaceuticals Inc. | KERX | 492515101 | 6/9/2015 | Elect Director Gregory P. Madison | Issuer | Yes | For | For |
| Keryx Biopharmaceuticals Inc. | KERX | 492515101 | 6/9/2015 | Elect Director Daniel P. Regan | Issuer | Yes | For | For |
| Keryx Biopharmaceuticals Inc. | KERX | 492515101 | 6/9/2015 | Elect Director Michael P. Tarnok | Issuer | Yes | For | For |
| Keryx Biopharmaceuticals Inc. | KERX | 492515101 | 6/9/2015 | Ratify UHY LLP as Auditors | Issuer | Yes | For | For |
| Keryx Biopharmaceuticals Inc. | KERX | 492515101 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Elect Director Jason M. Aryeh | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Elect Director Todd C. Davis | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Elect Director John L. Higgins | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Elect Director David M. Knott | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Elect Director John W. Kozarich | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Elect Director John L. LaMattina | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Elect Director Sunil Patel | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Elect Director Stephen L. Sabba | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Ratify Grant Thornton LLP as Auditors | Issuer | Yes | For | For |
| Ligand Pharmaceuticals Incorporated | LGND | 53220K504 | 4/24/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| MannKind Corp. | MNKD | 56400P201 | 5/21/2015 | Elect Director Alfred E. Mann | Issuer | Yes | For | For |
| MannKind Corp. | MNKD | 56400P201 | 5/21/2015 | Elect Director Hakan S. Edstrom | Issuer | Yes | For | For |
| MannKind Corp. | MNKD | 56400P201 | 5/21/2015 | Elect Director Ronald J. Consiglio | Issuer | Yes | For | For |
| MannKind Corp. | MNKD | 56400P201 | 5/21/2015 | Elect Director Michael A. Friedman | Issuer | Yes | For | For |
| MannKind Corp. | MNKD | 56400P201 | 5/21/2015 | Elect Director Kent Kresa | Issuer | Yes | For | For |
| MannKind Corp. | MNKD | 56400P201 | 5/21/2015 | Elect Director David H. MacCallum | Issuer | Yes | For | For |
| MannKind Corp. | MNKD | 56400P201 | 5/21/2015 | Elect Director Henry L. Nordhoff | Issuer | Yes | For | For |
| MannKind Corp. | MNKD | 56400P201 | 5/21/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| MannKind Corp. | MNKD | 56400P201 | 5/21/2015 | Ratify Deloitte & Touche LLP as Auditors | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Elect Director Kim D. Blickenstaff | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Elect Director Katherine F. Falberg | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Elect Director David T. Hung | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Elect Director C. Patrick Machado | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Elect Director Dawn Svoronos | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Elect Director W. Anthony Vernon | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Elect Director Wendy L. Yarno | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Amend 2004 Employye Stock Incentive Plan | Issuer | Yes | For | For |
| Medivation, Inc. | MDVN | 58501N101 | 6/9/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Nektar Therapeutics | NKTR | 640268108 | 6/9/2015 | Elect Director Robert B. Chess | Issuer | Yes | For | For |
| Nektar Therapeutics | NKTR | 640268108 | 6/9/2015 | Elect Director Susan Wang | Issuer | Yes | For | For |
| Nektar Therapeutics | NKTR | 640268108 | 6/9/2015 | Elect Director Roy Whitfield | Issuer | Yes | For | For |
| Nektar Therapeutics | NKTR | 640268108 | 6/9/2015 | Amend 20012 Performance Incentive Plan | Issuer | Yes | For | For |
| Nektar Therapeutics | NKTR | 640268108 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| PDL BioPharma, Inc. | PDLI | 69329Y104 | 5/28/2015 | Elect Director Jody S. Lindell | Issuer | Yes | For | For |
| PDL BioPharma, Inc. | PDLI | 69329Y104 | 5/28/2015 | Elect Director John P. McLaughlin | Issuer | Yes | For | For |
| PDL BioPharma, Inc. | PDLI | 69329Y104 | 5/28/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| PDL BioPharma, Inc. | PDLI | 69329Y104 | 5/28/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| PDL BioPharma, Inc. | PDLI | 69329Y104 | 5/28/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Progenics Pharmaceuticals, Inc. | PGNX | 743187106 | 6/10/2015 | Elect Director Peter J. Crowley | Issuer | Yes | For | For |
| Progenics Pharmaceuticals, Inc. | PGNX | 743187106 | 6/10/2015 | Elect Director Paul J. Maddon | Issuer | Yes | For | For |
| Progenics Pharmaceuticals, Inc. | PGNX | 743187106 | 6/10/2015 | Elect Director Mark R. Baker t | Issuer | Yes | For | For |
| Progenics Pharmaceuticals, Inc. | PGNX | 743187106 | 6/10/2015 | Elect Director Karen J. Ferrante | Issuer | Yes | For | For |
| Progenics Pharmaceuticals, Inc. | PGNX | 743187106 | 6/10/2015 | Elect Director Michael D. Kishbauch | Issuer | Yes | For | For |
| Progenics Pharmaceuticals, Inc. | PGNX | 743187106 | 6/10/2015 | Elect Director David A. Scheinberg | Issuer | Yes | For | For |
| Progenics Pharmaceuticals, Inc. | PGNX | 743187106 | 6/10/2015 | Elect Director Nicole S. Williams | Issuer | Yes | For | For |
| Progenics Pharmaceuticals, Inc. | PGNX | 743187106 | 6/10/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Progenics Pharmaceuticals, Inc. | PGNX | 743187106 | 6/10/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Raptor Pharmaceuticals Corp. | RPTP | 75382F106 | 5/5/2015 | Elect Director Raymond W. Anderson | Issuer | Yes | For | For |
| Raptor Pharmaceuticals Corp. | RPTP | 75382F106 | 5/5/2015 | Elect Director Suzanne L. Bruhn | Issuer | Yes | For | For |
| Raptor Pharmaceuticals Corp. | RPTP | 75382F106 | 5/5/2015 | Elect Director Richard L. Franklin | Issuer | Yes | For | For |
| Raptor Pharmaceuticals Corp. | RPTP | 75382F106 | 5/5/2015 | Elect Director Georges Gemayel | Issuer | Yes | For | For |
| Raptor Pharmaceuticals Corp. | RPTP | 75382F106 | 5/5/2015 | Elect Director Llew Keltner | Issuer | Yes | For | For |
| Raptor Pharmaceuticals Corp. | RPTP | 75382F106 | 5/5/2015 | Elect Director Gregg Lapointe | Issuer | Yes | For | For |
| Raptor Pharmaceuticals Corp. | RPTP | 75382F106 | 5/5/2015 | Elect Director Julie Anne Smith | Issuer | Yes | For | For |
| Raptor Pharmaceuticals Corp. | RPTP | 75382F106 | 5/5/2015 | Elect Director Christopher M. Starr | Issuer | Yes | For | For |
| Raptor Pharmaceuticals Corp. | RPTP | 75382F106 | 5/5/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Regenron Pharmaceiticals | REGN | 75886F107 | 6/12/2015 | Elect Director Charles A. Baker | Issuer | Yes | For | For |
| Regenron Pharmaceiticals | REGN | 75886F107 | 6/12/2015 | Elect Director Arthur F. Ryan | Issuer | Yes | For | For |
| Regenron Pharmaceiticals | REGN | 75886F107 | 6/12/2015 | Elect Director George L. Sing | Issuer | Yes | For | For |
| Regenron Pharmaceiticals | REGN | 75886F107 | 6/12/2015 | Elect Director Marc Tessier-Lavigne | Issuer | Yes | For | For |
| Regenron Pharmaceiticals | REGN | 75886F107 | 6/12/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Regenron Pharmaceiticals | REGN | 75886F107 | 6/12/2015 | Approve Executive Incentive Bonus Plan | Issuer | Yes | For | For |
| Regenron Pharmaceiticals | REGN | 75886F107 | 6/12/2015 | Increase Authorized Common Stock | Issuer | Yes | For | For |
| Regenron Pharmaceiticals | REGN | 75886F107 | 6/12/2015 | Proxy Access | Issuer | Yes | For | For |
| Seattle Genetics, Inc. | SGEN | 812578102 | 5/15/2015 | Elect Director Clay B. Siegall | Issuer | Yes | For | For |
| Seattle Genetics, Inc. | SGEN | 812578102 | 5/15/2015 | Elect Director Felix Baker | Issuer | Yes | For | For |
| Seattle Genetics, Inc. | SGEN | 812578102 | 5/15/2015 | Elect Director Nancy A. Simonian | Issuer | Yes | For | For |
| Seattle Genetics, Inc. | SGEN | 812578102 | 5/15/2015 | Amend Qualified Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Seattle Genetics, Inc. | SGEN | 812578102 | 5/15/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Seattle Genetics, Inc. | SGEN | 812578102 | 5/15/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| The Medicines Company | MDCO | 584688105 | 5/28/2015 | Elect Director Armin M. Kessler | Issuer | Yes | For | For |
| The Medicines Company | MDCO | 584688105 | 5/28/2015 | Elect Director Robert G. Savage | Issuer | Yes | For | For |
| The Medicines Company | MDCO | 584688105 | 5/28/2015 | Elect Director Glenn P. Sblendorio | Issuer | Yes | For | For |
| The Medicines Company | MDCO | 584688105 | 5/28/2015 | Elect Director Melvin K. Spigelman | Issuer | Yes | For | For |
| The Medicines Company | MDCO | 584688105 | 5/28/2015 | Increase Authorized Common Stock | Issuer | Yes | For | For |
| The Medicines Company | MDCO | 584688105 | 5/28/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| The Medicines Company | MDCO | 584688105 | 5/28/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| The Medicines Company | MDCO | 584688105 | 5/28/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Theravance Biopharma, Inc. | TBPH | G8807B106 | 4/22/2015 | Elect Director Eran Broshy | Issuer | Yes | For | For |
| Theravance Biopharma, Inc. | TBPH | G8807B106 | 4/22/2015 | Elect Director Henrietta H. Fore | Issuer | Yes | For | For |
| Theravance Biopharma, Inc. | TBPH | G8807B106 | 4/22/2015 | Elect Director Burton G. Malkiel | Issuer | Yes | For | For |
| Theravance Biopharma, Inc. | TBPH | G8807B106 | 4/22/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| United Therapeutics Corporation | UTHR | 91307C102 | 6/9/2015 | Elect Director Katherine Klein | Issuer | Yes | For | For |
| United Therapeutics Corporation | UTHR | 91307C102 | 6/9/2015 | Elect Director Raymond Kurzweil | Issuer | Yes | For | For |
| United Therapeutics Corporation | UTHR | 91307C102 | 6/9/2015 | Elect Director Martine Rothblatt | Issuer | Yes | For | For |
| United Therapeutics Corporation | UTHR | 91307C102 | 6/9/2015 | Elect Director Louis Sullivan | Issuer | Yes | For | For |
| United Therapeutics Corporation | UTHR | 91307C102 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| United Therapeutics Corporation | UTHR | 91307C102 | 6/9/2015 | Approve Omnibus Stock Plan | Issuer | Yes | For | For |
| United Therapeutics Corporation | UTHR | 91307C102 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Vanda Pharmaceuticals, Inc. | VNDA | 921659108 | 6/9/2015 | Elect Director M.H. Polymeropoulos | Issuer | Yes | For | For |
| Vanda Pharmaceuticals, Inc. | VNDA | 921659108 | 6/9/2015 | Ratify Pricewaterhose Coopers LLP AS Auditor | Issuer | Yes | For | For |
| Vanda Pharmaceuticals, Inc. | VNDA | 921659108 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Vanda Pharmaceuticals, Inc. | VNDA | 921659108 | 6/9/2015 | Amend 2006 Equity Incetive Plan | Issuer | Yes | For | For |
| Vertex Pharmaceuticals Incorporated | VRTX | 92532F100 | 6/9/2015 | Elect Director Jeffrey M. Leiden | Issuer | Yes | For | For |
| Vertex Pharmaceuticals Incorporated | VRTX | 92532F100 | 6/9/2015 | Elect Director Bruce I. Sachs | Issuer | Yes | For | For |
| Vertex Pharmaceuticals Incorporated | VRTX | 92532F100 | 6/9/2015 | Elect Director Sangeeta N. Bhatia | Issuer | Yes | For | For |
| Vertex Pharmaceuticals Incorporated | VRTX | 92532F100 | 6/9/2015 | Increase Authorized Common Stock | Issuer | Yes | For | For |
| Vertex Pharmaceuticals Incorporated | VRTX | 92532F100 | 6/9/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Vertex Pharmaceuticals Incorporated | VRTX | 92532F100 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Vertex Pharmaceuticals Incorporated | VRTX | 92532F100 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Vertex Pharmaceuticals Incorporated | VRTX | 92532F100 | 6/9/2015 | Adopt Proxy Access Right | Issuer | Yes | For | For |
| Vertex Pharmaceuticals Incorporated | VRTX | 92532F100 | 6/9/2015 | Report on Specialty Drug Pricing Risks | Issuer | Yes | For | For |
================= BIOSHARES BIOTECHNOLOGY CLINICAL TRIALS FUND ==================
| Issuer of Portfolio Security | Exchange Ticker Symbol | CUSIP # | Shareholder Meeting Date | Summary of Matter Voted On | Who Proposed Matter: Issuer / Shareholder | Whether Fund Cast Vote on Matter | Fund's Vote For or Against Proposal, or Abstain; For or Withhold Regarding Election of Directors | Whether Vote Was For or Against Management |
| ACADIA Pharmaceuticals Inc. | ACAD | 004225108 | 6/15/2015 | Elect Director Stephen R. Biggar | Issuer | Yes | For | For |
| ACADIA Pharmaceuticals Inc. | ACAD | 004225108 | 6/15/2015 | Elect Director Torsten Rasmussen | Issuer | Yes | For | For |
| ACADIA Pharmaceuticals Inc. | ACAD | 004225108 | 6/15/2015 | Elect Director Daniel Soland | Issuer | Yes | For | For |
| ACADIA Pharmaceuticals Inc. | ACAD | 004225108 | 6/15/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| ACADIA Pharmaceuticals Inc. | ACAD | 004225108 | 6/15/2015 | Increase Authorized Common Stock | Issuer | Yes | For | For |
| ACADIA Pharmaceuticals Inc. | ACAD | 004225108 | 6/15/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| ACADIA Pharmaceuticals Inc. | ACAD | 004225108 | 6/15/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Acceleron Pharma, Inc. | XLRN | 00434H108 | 6/4/2015 | Elect Director Terrence C. Kearney | Issuer | Yes | For | For |
| Acceleron Pharma, Inc. | XLRN | 00434H108 | 6/4/2015 | Elect Director John L. Knopf | Issuer | Yes | For | For |
| Acceleron Pharma, Inc. | XLRN | 00434H108 | 6/4/2015 | Elect Director Terrance G. McGuire | Issuer | Yes | For | For |
| Acceleron Pharma, Inc. | XLRN | 00434H108 | 6/4/2015 | Advisory Vote on Say on Pay Frequency | Issuer | Yes | For | For |
| Acceleron Pharma, Inc. | XLRN | 00434H108 | 6/4/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Achillion Pharmaceuticals, Inc. | ACHN | 00448Q201 | 6/2/2015 | Elect Director Milind S. Deshpande | Issuer | Yes | For | For |
| Achillion Pharmaceuticals, Inc. | ACHN | 00448Q201 | 6/2/2015 | Elect Director Jason S. Fisherman | Issuer | Yes | For | For |
| Achillion Pharmaceuticals, Inc. | ACHN | 00448Q201 | 6/2/2015 | Elect Director Gary E. Frashier | Issuer | Yes | For | For |
| Achillion Pharmaceuticals, Inc. | ACHN | 00448Q201 | 6/2/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Achillion Pharmaceuticals, Inc. | ACHN | 00448Q201 | 6/2/2015 | Amend Qualified Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Achillion Pharmaceuticals, Inc. | ACHN | 00448Q201 | 6/2/2015 | Approve Omnibus Stock Plan | Issuer | Yes | For | For |
| Achillion Pharmaceuticals, Inc. | ACHN | 00448Q201 | 6/2/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Agios Pharmaceuticals, Inc. | AGIO | 00847X104 | 6/23/2015 | Elect Director Douglas G. Cole | Issuer | Yes | For | For |
| Agios Pharmaceuticals, Inc. | AGIO | 00847X104 | 6/23/2015 | Elect Director Kaye Foster-Cheek | Yes | For | For | |
| Agios Pharmaceuticals, Inc. | AGIO | 00847X104 | 6/23/2015 | Elect Director John A Maraganore | Yes | For | For | |
| Agios Pharmaceuticals, Inc. | AGIO | 00847X104 | 6/23/2015 | Ratify Ernst & Young LLP as Auditors | Yes | For | For | |
| Alder Biopharmaceuticals Inc. | ALDR | 014339105 | 5/19/2015 | Elect Director Stephen M. Dow | Issuer | Yes | For | For |
| Alder Biopharmaceuticals Inc. | ALDR | 014339105 | 5/19/2015 | Elect Director A. Bruce Montgomery | Issuer | Yes | For | For |
| Alder Biopharmaceuticals Inc. | ALDR | 014339105 | 5/19/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Alnylam Pharmaceuticals, Inc. | ALNY | 02043Q107 | 5/1/2015 | Elect Director Dennis A. Ausiello | Issuer | Yes | For | For |
| Alnylam Pharmaceuticals, Inc. | ALNY | 02043Q107 | 5/1/2015 | Elect Director John K. Clark | Issuer | Yes | For | For |
| Alnylam Pharmaceuticals, Inc. | ALNY | 02043Q107 | 5/1/2015 | Elect Director Marsha A. Fanuucci | Issuer | Yes | For | For |
| Alnylam Pharmaceuticals, Inc. | ALNY | 02043Q107 | 5/1/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Amicus Therapeutics, Inc. | FOLD | 03152W109 | 6/10/2015 | Elect Director Sol J. Barer | Issuer | Yes | For | For |
| Amicus Therapeutics, Inc. | FOLD | 03152W109 | 6/10/2015 | Elect Director Donald J. Hayden, Jr. | Issuer | Yes | For | For |
| Amicus Therapeutics, Inc. | FOLD | 03152W109 | 6/10/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Amicus Therapeutics, Inc. | FOLD | 03152W109 | 6/10/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Amicus Therapeutics, Inc. | FOLD | 03152W109 | 6/10/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Avalanche Biotechnologies, Inc. | AAVL | 05337G107 | 6/9/2015 | Elect Director Thomas W Chalberg, Jr. | Issuer | Yes | For | For |
| Avalanche Biotechnologies, Inc. | AAVL | 05337G107 | 6/9/2015 | Elect Director Paul D. Wacher | Issuer | Yes | For | For |
| Avalanche Biotechnologies, Inc. | AAVL | 05337G107 | 6/9/2015 | Ratify Deloitte & Touche LLP as Auditors | Issuer | Yes | For | For |
| BioCryst Pharmaceuticals, Inc. | BCRX | 09058V103 | 5/20/2015 | Elect Director Nancy J. Hutson | Issuer | Yes | For | For |
| BioCryst Pharmaceuticals, Inc. | BCRX | 09058V103 | 5/20/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| bluebird bio, Inc. | BLUE | 09609G100 | 6/4/2015 | Elect Director Daniel S. Lynch | Issuer | Yes | For | For |
| bluebird bio, Inc. | BLUE | 09609G100 | 6/4/2015 | Elect Director John M. Maraganore | Issuer | Yes | For | For |
| bluebird bio, Inc. | BLUE | 09609G100 | 6/4/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| bluebird bio, Inc. | BLUE | 09609G100 | 6/4/2015 | Advisory Vote on Say on Pay Frequency Three One Year Management | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Elect Director Larry Ellberger | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Elect Director Anthony S. Marucci | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Elect Director Herbert J. Conrad | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Elect Director George O. Elston | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Elect Director Harry H. Penner, Jr. | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Elect Director Karen L. Shoos | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Elect Director Richard A. van den Broek | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Celldex Therapeutics, Inc. | CLDX | 15117B103 | 6/10/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Cempra, Inc. | CEMP | 15130J109 | 5/21/2015 | Elect Director Michael R. Dougherty | Issuer | Yes | For | For |
| Cempra, Inc. | CEMP | 15130J109 | 5/21/2015 | Elect Director Prabhavathi Fernandes | Issuer | Yes | For | For |
| Cempra, Inc. | CEMP | 15130J109 | 5/21/2015 | Elect Director David Gill | Issuer | Yes | For | For |
| Cempra, Inc. | CEMP | 15130J109 | 5/21/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Cempra, Inc. | CEMP | 15130J109 | 5/21/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Chimerix, Inc. | CMRX | 16934W106 | 6/22/2015 | Elect Director James M. Daly | Issuer | Yes | For | For |
| Chimerix, Inc. | CMRX | 16934W106 | 6/22/2015 | Elect Director Martha J. Demski | Issuer | Yes | For | For |
| Chimerix, Inc. | CMRX | 16934W106 | 6/22/2015 | Elect Director John M. Leonard | Issuer | Yes | For | For |
| Chimerix, Inc. | CMRX | 16934W106 | 6/22/2015 | Elect Director James Niedel | Issuer | Yes | For | For |
| Chimerix, Inc. | CMRX | 16934W106 | 6/22/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Clovis Oncology, Inc. | CLVS | 189464100 | 6/11/2015 | Elect Director M. James Barrett | Issuer | Yes | For | For |
| Clovis Oncology, Inc. | CLVS | 189464100 | 6/11/2015 | Elect Director Patrick J. Mahaffy | Issuer | Yes | For | For |
| Clovis Oncology, Inc. | CLVS | 189464100 | 6/11/2015 | Elect Director Thorlef Spickschen | Issuer | Yes | For | For |
| Clovis Oncology, Inc. | CLVS | 189464100 | 6/11/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Clovis Oncology, Inc. | CLVS | 189464100 | 6/11/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Dynavax Technologies Corporation | DVAX | 268158201 | 5/27/2015 | Elect Director Arnold L. Oronsky | Issuer | Yes | For | For |
| Dynavax Technologies Corporation | DVAX | 268158201 | 5/27/2015 | Elect Director Francis R. Cano | Issuer | Yes | For | For |
| Dynavax Technologies Corporation | DVAX | 268158201 | 5/27/2015 | Elect Director Peggy V. Phillips | Issuer | Yes | For | For |
| Dynavax Technologies Corporation | DVAX | 268158201 | 5/27/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Dynavax Technologies Corporation | DVAX | 268158201 | 5/27/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Endocyte, Inc. | ECYT | 29269A102 | 5/14/2015 | Elect Director Keith E. Brauer | Issuer | Yes | For | For |
| Endocyte, Inc. | ECYT | 29269A102 | 5/14/2015 | Elect Director Ann F. Hanham | Issuer | Yes | For | For |
| Endocyte, Inc. | ECYT | 29269A102 | 5/14/2015 | Elect Director Peter D. Meldrum | Issuer | Yes | For | For |
| Endocyte, Inc. | ECYT | 29269A102 | 5/14/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Epizyme, Inc | EPZM | 29428V104 | 5/19/2015 | Elect Director Carl Goldfischer | Issuer | Yes | For | For |
| Epizyme, Inc | EPZM | 29428V104 | 5/19/2015 | Elect Director Beth Seidenberg | Issuer | Yes | For | For |
| Epizyme, Inc | EPZM | 29428V104 | 5/19/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/14/2015 | Elect Director Antonio M. Gotto, Jr. | Issuer | Yes | For | For |
| Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/14/2015 | Elect Director Gilbert S Omenin | Issuer | Yes | For | For |
| Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/14/2015 | Elect Director Nicole Virtullo | Issuer | Yes | For | For |
| Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/14/2015 | Amend Qualified Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Esperion Therapeutics, Inc. | ESPR | 29664W105 | 5/14/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Geron Corporation | GERN | 374163103 | 5/18/2015 | Elect Director John Scarlett | Issuer | Yes | For | For |
| Geron Corporation | GERN | 374163103 | 5/18/2015 | Elect Director Robert J. Speigel | Issuer | Yes | For | For |
| Geron Corporation | GERN | 374163103 | 5/18/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Geron Corporation | GERN | 374163103 | 5/18/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Idera Pharmaceuticals, Inc. | IDRA | 45168K306 | 6/9/2015 | Elect Director Kelvin M. Neu | Issuer | Yes | For | For |
| Idera Pharmaceuticals, Inc. | IDRA | 45168K306 | 6/9/2015 | Elect Director William S. Reardon | Issuer | Yes | For | For |
| Idera Pharmaceuticals, Inc. | IDRA | 45168K306 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Idera Pharmaceuticals, Inc. | IDRA | 45168K306 | 6/9/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Idera Pharmaceuticals, Inc. | IDRA | 45168K306 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Elect Director Jose Baselga | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Elect Director Jeffrey Berkowitz | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Elect Director Anthony B. Envin | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Elect Director Gwen A. Fyfe | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Elect Director Eric S. Lander | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Elect Director Adelene Q. Perkins | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Elect Director Ian F. Smith | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Elect Director Michael C. Venuti | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Amend Qualified Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Infinity Pharmaceuticals, Inc. | INFI | 45665G303 | 6/15/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Insmed Incorporated | INSM | 457669307 | 5/21/2015 | Elect Director David R. Brennan | Issuer | Yes | For | For |
| Insmed Incorporated | INSM | 457669307 | 5/21/2015 | Elect Director Melvin Sharoky | Issuer | Yes | For | For |
| Insmed Incorporated | INSM | 457669307 | 5/21/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Insmed Incorporated | INSM | 457669307 | 5/21/2015 | Approve Omnibus Stock Plan | Issuer | Yes | For | For |
| Karyopharm Therapeutics, Inc. | KPTI | 48576U106 | 5/22/2015 | Elect Director Deepika R. Pakianathan | Issuer | Yes | For | For |
| Karyopharm Therapeutics, Inc. | KPTI | 48576U106 | 5/22/2015 | Elect Director Kenneth E. Weg | Issuer | Yes | For | For |
| Karyopharm Therapeutics, Inc. | KPTI | 48576U106 | 5/22/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Kite Pharma, Inc. | KITE | 49803L109 | 6/8/2015 | Elect Director Arie Belledegrum | Issuer | Yes | For | For |
| Kite Pharma, Inc. | KITE | 49803L109 | 6/8/2015 | Elect Director David Bonderman | Issuer | Yes | For | For |
| Kite Pharma, Inc. | KITE | 49803L109 | 6/8/2015 | Elect Director Jonathan Peacock | Issuer | Yes | For | For |
| Kite Pharma, Inc. | KITE | 49803L109 | 6/8/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Kythera Biopharmaceuticals, Inc. | KYTH | 501570105 | 6/2/2015 | Elect Director Keith R. Leonard, Jr. | Issuer | Yes | For | For |
| Kythera Biopharmaceuticals, Inc. | KYTH | 501570105 | 6/2/2015 | Elect Director Hollings C. Renton, III | Issuer | Yes | For | For |
| Kythera Biopharmaceuticals, Inc. | KYTH | 501570105 | 6/2/2015 | Elect Director Camille Samuels | Issuer | Yes | For | For |
| Kythera Biopharmaceuticals, Inc. | KYTH | 501570105 | 6/2/2015 | Approve Qualified Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Kythera Biopharmaceuticals, Inc. | KYTH | 501570105 | 6/2/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Lexicon Phramaceuticals | LXRX | 528872104 | 4/23/2015 | Elect Director Phillipe J. Amouyal | Issuer | Yes | For | For |
| Lexicon Phramaceuticals | LXRX | 528872104 | 4/23/2015 | Elect Director Lonnel Coats | Issuer | Yes | For | For |
| Lexicon Phramaceuticals | LXRX | 528872104 | 4/23/2015 | Elect Director Frank P. Palantoni | Issuer | Yes | For | For |
| Lexicon Phramaceuticals | LXRX | 528872104 | 4/23/2015 | Amend Omnibus Stock Plan and reverse stock split | Issuer | Yes | For | For |
| Lexicon Phramaceuticals | LXRX | 528872104 | 4/23/2015 | Amend Company's Equity Incentive Plan | Issuer | Yes | For | For |
| Lexicon Phramaceuticals | LXRX | 528872104 | 4/23/2015 | Amend Company's Non-Eomployee Directors' Equity Incentive Plan | Issuer | Yes | For | For |
| Lexicon Phramaceuticals | LXRX | 528872104 | 4/23/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Lexicon Phramaceuticals | LXRX | 528872104 | 4/23/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| MacroGenics, Inc. | MGNX | 556099109 | 5/20/2015 | Elect Director Kenneth Galbraith | Issuer | Yes | For | For |
| MacroGenics, Inc. | MGNX | 556099109 | 5/20/2015 | Elect Director David Stump | Issuer | Yes | For | For |
| MacroGenics, Inc. | MGNX | 556099109 | 5/20/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Elect Director Robert J. Mulroy | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 5903281010 | 5/12/2015 | Elect Director Gary L. Crocker | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Elect Director Gordon J. Fehr | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Elect Director Vivian S. Lee | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Elect Director John Mendelsohn | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Elect Director Ulrik B. Nielsen | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Elect Director Michael E. Porter | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Elect Director James H. Quigley | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Elect Director Russell T. Ray | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Advisory Vote on Say on Pay Frequency One Year One Year Management | Issuer | Yes | For | For |
| Merrimack Pharmaceuticals, Inc. | MACK | 590328100 | 5/12/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Yes | For | For | |
| Momenta Pharmaceuticals Inc. | MNTA | 60877T100 | 6/9/2015 | Elect Director John K. Clark | Issuer | Yes | For | For |
| Momenta Pharmaceuticals Inc. | MNTA | 60877T100 | 6/9/2015 | Elect Director James R. Sulat | Issuer | Yes | For | For |
| Momenta Pharmaceuticals Inc. | MNTA | 60877T100 | 6/9/2015 | Elect Director Craig Wheeler | Issuer | Yes | For | For |
| Momenta Pharmaceuticals Inc. | MNTA | 60877T100 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Momenta Pharmaceuticals Inc. | MNTA | 60877T100 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Momenta Pharmaceuticals Inc. | MNTA | 60877T100 | 6/9/2015 | Amend 2013 Incentive Plan | Issuer | Yes | For | For |
| Neurocrine Biosciences Inc. | NBIX | 64125C108 | 5/28/2015 | Elect Director W. Thomas Mitchell | Issuer | Yes | For | For |
| Neurocrine Biosciences Inc. | NBIX | 64125C108 | 5/28/2015 | Elect Director Joseph A. Mollica | Issuer | Yes | For | For |
| Neurocrine Biosciences Inc. | NBIX | 64125C108 | 5/28/2015 | Elect Director William H. Rastetter | Issuer | Yes | For | For |
| Neurocrine Biosciences Inc. | NBIX | 64125C108 | 5/28/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Neurocrine Biosciences Inc. | NBIX | 64125C108 | 5/28/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Neurocrine Biosciences Inc. | NBIX | 64125C108 | 5/28/2015 | Ratify Ernst & Young LLP as Auditors t | Issuer | Yes | For | For |
| Novavax, Inc. | NVAX | 670002104 | 6/18/2015 | Elect Director Richard H. Douglas | Issuer | Yes | For | For |
| Novavax, Inc. | NVAX | 670002104 | 6/18/2015 | Elect Director Gary C. Evans | Issuer | Yes | For | For |
| Novavax, Inc. | NVAX | 670002104 | 6/18/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Novavax, Inc. | NVAX | 670002104 | 6/18/2015 | Amend By-Laws to adopt forum selection clause | Issuer | Yes | For | For |
| Novavax, Inc. | NVAX | 670002104 | 6/18/2015 | Approve 2015 Stock Incentive Plan | Issuer | Yes | For | For |
| Novavax, Inc. | NVAX | 670002104 | 6/18/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Omeros Corporation | OMER | 682143102 | 5/22/2015 | Elect Director Gregory A. Demopulos | Issuer | Yes | For | For |
| Omeros Corporation | OMER | 682143102 | 5/22/2015 | Elect Director Leroy E. Hood | Issuer | Yes | For | For |
| Omeros Corporation | OMER | 682143102 | 5/22/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| OncoMed Pharmaceuticals, Inc. | OMED | 68234X102 | 6/19/2015 | Elect Director Paul J. Hastings | Issuer | Yes | For | For |
| OncoMed Pharmaceuticals, Inc. | OMED | 68234X102 | 6/19/2015 | Elect Director Laurence Lasky | Issuer | Yes | For | For |
| OncoMed Pharmaceuticals, Inc. | OMED | 68234X102 | 6/19/2015 | Elect Director Denise Pollard-Knight | Issuer | Yes | For | For |
| OncoMed Pharmaceuticals, Inc. | OMED | 68234X102 | 6/19/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Ophthotech Corporation | OPHT | 683745103 | 6/9/2015 | Elect Director Axel Bolte | Issuer | Yes | For | For |
| Ophthotech Corporation | OPHT | 683745103 | 6/9/2015 | Elect Director Samir C. Patel | Issuer | Yes | For | For |
| Ophthotech Corporation | OPHT | 683745103 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Orexigen Therapeutics, Inc. | OREX | 686164104 | 6/9/2015 | Elect Director Louis Bock | Issuer | Yes | For | For |
| Orexigen Therapeutics, Inc. | OREX | 686164104 | 6/9/2015 | Elect Director Wendy L. Dixon | Issuer | Yes | For | For |
| Orexigen Therapeutics, Inc. | OREX | 686164104 | 6/9/2015 | Elect Director Peter K. Honig | Issuer | Yes | For | For |
| Orexigen Therapeutics, Inc. | OREX | 686164104 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Portola Pharmaceuticals, Inc. | PTLA | 737010108 | 6/16/2015 | Elect Director Charles J. Homcy | Issuer | Yes | For | For |
| Portola Pharmaceuticals, Inc. | PTLA | 737010108 | 6/16/2015 | Elect Director Dennis Fenton t | Issuer | Yes | For | For |
| Portola Pharmaceuticals, Inc. | PTLA | 737010108 | 6/16/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Portola Pharmaceuticals, Inc. | PTLA | 737010108 | 6/16/2015 | Advisory Vote on Say on Pay Frequency One Year One Year | Issuer | Yes | For | For |
| Portola Pharmaceuticals, Inc. | PTLA | 737010108 | 6/16/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Prothena Corporation plc | PRTA | G72800108 | 5/21/2015 | Elect Director Shane M. Cooke | Issuer | Yes | For | For |
| Prothena Corporation plc | PRTA | G72800108 | 5/21/2015 | Elect Director Lars G. Ekman | Issuer | Yes | For | For |
| Prothena Corporation plc | PRTA | G72800108 | 5/21/2015 | Ratify KPMG LLP as Auditors | Issuer | Yes | For | For |
| PTC Therapeutics, Inc. | PTCT | 69366J200 | 6/10/2015 | Elect Director Adam Koppel | Issuer | Yes | For | For |
| PTC Therapeutics, Inc. | PTCT | 69366J200 | 6/10/2015 | Elect Director Michael Schmertzler | Issuer | Yes | For | For |
| PTC Therapeutics, Inc. | PTCT | 69366J200 | 6/10/2015 | Elect Director Glenn D. Steele Jr. | Issuer | Yes | For | For |
| PTC Therapeutics, Inc. | PTCT | 69366J200 | 6/10/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Puma Biotechnology, Inc. | PBYI | 74587V107 | 6/9/2015 | Elect Director Alan H. Auerbach | Issuer | Yes | For | For |
| Puma Biotechnology, Inc. | PBYI | 74587V107 | 6/9/2015 | Elect Director Thomas A. Malley | Issuer | Yes | For | For |
| Puma Biotechnology, Inc. | PBYI | 74587V107 | 6/9/2015 | Elect Director Jay M. Moyes | Issuer | Yes | For | For |
| Puma Biotechnology, Inc. | PBYI | 74587V107 | 6/9/2015 | Elect Director Troy E. Wilson | Issuer | Yes | For | For |
| Puma Biotechnology, Inc. | PBYI | 74587V107 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Puma Biotechnology, Inc. | PBYI | 74587V107 | 6/9/2015 | Ratify PKF Certified Public Accountants as Auditors | Issuer | Yes | For | For |
| Puma Biotechnology, Inc. | PBYI | 74587V107 | 6/9/2015 | Amend 2011 Incetive Award Plan | Issuer | Yes | For | For |
| Receptos, Inc. | RCPT | 756207106 | 5/28/2015 | Elect Director Joseph S. Podolski | Issuer | Yes | For | For |
| Receptos, Inc. | RCPT | 756207106 | 5/28/2015 | Elect Director Daniel F. Cain | Issuer | Yes | For | For |
| Receptos, Inc. | RCPT | 756207106 | 5/28/2015 | Elect Director Nola E. Masterson | Issuer | Yes | For | For |
| Receptos, Inc. | RCPT | 756207106 | 5/28/2015 | Elect Director Saira Ramasastry | Issuer | Yes | For | For |
| Receptos, Inc. | RCPT | 756207106 | 5/28/2015 | Elect Director Michael Suesserman | Issuer | Yes | For | For |
| Receptos, Inc. | RCPT | 756207106 | 5/28/2015 | Elect Director Michael G. Wyllie | Issuer | Yes | For | For |
| Receptos, Inc. | RCPT | 756207106 | 5/28/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Receptos, Inc. | RCPT | 756207106 | 5/28/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Regulus Therapeutics Inc. | RGLS | 75915K101 | 6/10/2015 | Elect Director David Baltimore | Issuer | Yes | For | For |
| Regulus Therapeutics Inc. | RGLS | 75915K101 | 6/10/2015 | Elect Director Bruce Carter | Issuer | Yes | For | For |
| Regulus Therapeutics Inc. | RGLS | 75915K101 | 6/10/2015 | Elect Director Mark Foletta | Issuer | Yes | For | For |
| Regulus Therapeutics Inc. | RGLS | 75915K101 | 6/10/2015 | Elect Director Stelios Papadopoulus | Issuer | Yes | For | For |
| Regulus Therapeutics Inc. | RGLS | 75915K101 | 6/10/2015 | Elect Director William Rastetter | Issuer | Yes | For | For |
| Regulus Therapeutics Inc. | RGLS | 75915K101 | 6/10/2015 | Elect Director Douglas Williams | Issuer | Yes | For | For |
| Regulus Therapeutics Inc. | RGLS | 75915K101 | 6/10/2015 | Elect Director Kleanthis Xanthouoplos | Issuer | Yes | For | For |
| Regulus Therapeutics Inc. | RGLS | 75915K101 | 6/10/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Relypsa, Inc. | RLYP | 759531106 | 6/4/2015 | Elect Director David WJ McGirr | Issuer | Yes | For | For |
| Relypsa, Inc. | RLYP | 759531106 | 6/4/2015 | Elect Director John A. Orwin | Issuer | Yes | For | For |
| Relypsa, Inc. | RLYP | 759531106 | 6/4/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Elect Director Stephen Aselage | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Elect Director Tim Coughlin | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Elect Director Cornelius E. Golding | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Elect Director John Kozarich | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Elect Director Gary Lyons | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Elect Director Jeffrey Meckler | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Amend By-Laws | Issuer | Yes | For | For |
| Retrophin, Inc. | RTRX | 761299106 | 6/9/2015 | Ratify BDO USA, LLP as Auditors | Issuer | Yes | For | For |
| Sage Therapeutics, Inc. | SAGE | 78667J108 | 5/28/2015 | Elect Director Steven Paul | Issuer | Yes | For | For |
| Sage Therapeutics, Inc. | SAGE | 78667J108 | 5/28/2015 | Elect Director Robert T. Nelsen | Issuer | Yes | For | For |
| Sage Therapeutics, Inc. | SAGE | 78667J108 | 5/28/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Sage Therapeutics, Inc. | SAGE | 78667J108 | 5/28/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Elect Director Edward O. Lanphier II | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Elect Director Paul B. Cleveland | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Elect Director Stephen G. Dilly | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Elect Director John W. Larson | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Elect Director Stephen J. Mento | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Elect Director H. Stewart Parker | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Elect Director Saira Ramasastry | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Elect Director William R. Ringo | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Amend 2013 Stock Incentive Plan | Issuer | Yes | For | For |
| Sangamo Biosciences Inc. | SGMO | 800677106 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Sarepta Therapeutics, Inc. | SRPT | 803607100 | 6/2/2015 | Elect Director M. Kathleen Behrens | Issuer | Yes | For | For |
| Sarepta Therapeutics, Inc. | SRPT | 803607100 | 6/2/2015 | Elect Director Richard J. Barry | Issuer | Yes | For | For |
| Sarepta Therapeutics, Inc. | SRPT | 803607100 | 6/2/2015 | Elect Director Claude Nicaise | Issuer | Yes | For | For |
| Sarepta Therapeutics, Inc. | SRPT | 803607100 | 6/2/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| Sarepta Therapeutics, Inc. | SRPT | 803607100 | 6/2/2015 | Amend Certificate of Incorporation | Issuer | Yes | For | For |
| Sarepta Therapeutics, Inc. | SRPT | 803607100 | 6/2/2015 | Amend 2011 Stock Incentive Plan | Issuer | Yes | For | For |
| Sarepta Therapeutics, Inc. | SRPT | 803607100 | 6/2/2015 | Ratify KPMG LLP as Auditors | Issuer | Yes | For | For |
| Synergy Pharmaceuticals, Inc. | SGYP | 871639308 | 6/8/2015 | Elect Director Gary S. Jacob | Issuer | Yes | For | For |
| Synergy Pharmaceuticals, Inc. | SGYP | 871639308 | 6/8/2015 | Elect Director Melvin K. Spigelman | Issuer | Yes | For | For |
| Synergy Pharmaceuticals, Inc. | SGYP | 871639308 | 6/8/2015 | Elect Director John S. Brancaccio | Issuer | Yes | For | For |
| Synergy Pharmaceuticals, Inc. | SGYP | 871639308 | 6/8/2015 | Elect Director Thomas H. Adams | Issuer | Yes | For | For |
| Synergy Pharmaceuticals, Inc. | SGYP | 871639308 | 6/8/2015 | Elect Director Christopher McGuigan | Issuer | Yes | For | For |
| Synergy Pharmaceuticals, Inc. | SGYP | 871639308 | 6/8/2015 | Elect Director Alan F. Joslyn | Issuer | Yes | For | For |
| Synergy Pharmaceuticals, Inc. | SGYP | 871639308 | 6/8/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Synergy Pharmaceuticals, Inc. | SGYP | 871639308 | 6/8/2015 | Amend 2008 Stock Incentive Plan | Issuer | Yes | For | For |
| Synergy Pharmaceuticals, Inc. | SGYP | 871639308 | 6/8/2015 | Ratify BBO USA, LLP as Auditors | Issuer | Yes | For | For |
| Synta Pharmaceuticals Corp. | SNTA | 87162T206 | 6/11/2015 | Elect Director Keith R. Gollust | Issuer | Yes | For | For |
| Synta Pharmaceuticals Corp. | SNTA | 87162T206 | 6/11/2015 | Elect Director Robert N. Wilson | Issuer | Yes | For | For |
| Synta Pharmaceuticals Corp. | SNTA | 87162T206 | 6/11/2015 | Ratify Ernst & Young, LLP as Auditors | Issuer | Yes | For | For |
| Tetraphase Pharmaceuticals, Inc. | TTPH | 88165N105 | 6/10/2015 | Elect Director Jeffrey Chodakewitz | Issuer | Yes | For | For |
| Tetraphase Pharmaceuticals, Inc. | TTPH | 88165N105 | 6/10/2015 | Elect Director Gerri Henwood | Issuer | Yes | For | For |
| Tetraphase Pharmaceuticals, Inc. | TTPH | 88165N105 | 6/10/2015 | Elect Director Guy MacDonald | Issuer | Yes | For | For |
| Tetraphase Pharmaceuticals, Inc. | TTPH | 88165N105 | 6/10/2015 | Ratify Ernst & Young, LLP as Auditors | Issuer | Yes | For | For |
| TG Therapeutics, Inc. | TGTX | 88322Q108 | 6/4/2015 | Elect Director Laurence Charney | Issuer | Yes | For | For |
| TG Therapeutics, Inc. | TGTX | 88322Q108 | 6/4/2015 | Elect Director Yann Echerlard | Issuer | Yes | For | For |
| TG Therapeutics, Inc. | TGTX | 88322Q108 | 6/4/2015 | Elect Director William J. Kennedy | Issuer | Yes | For | For |
| TG Therapeutics, Inc. | TGTX | 88322Q108 | 6/4/2015 | Elect Director Kenneth Hobberman | Issuer | Yes | For | For |
| TG Therapeutics, Inc. | TGTX | 88322Q108 | 6/4/2015 | Elect Director Daniel Hume | Issuer | Yes | For | For |
| TG Therapeutics, Inc. | TGTX | 88322Q108 | 6/4/2015 | Elect Director Mark Schoenebaum | Issuer | Yes | For | For |
| TG Therapeutics, Inc. | TGTX | 88322Q108 | 6/4/2015 | Elect Director Michael Weiss | Issuer | Yes | For | For |
| TG Therapeutics, Inc. | TGTX | 88322Q108 | 6/4/2015 | Ratify CohnReznick LLP as Auditor | Issuer | Yes | For | For |
| TG Therapeutics, Inc. | TGTX | 88322Q108 | 6/4/2015 | Amend 2012 Stock Incentive Plan | Issuer | Yes | For | For |
| Tokai Pharmaceuticals, Inc. | TKAI | 88907J107 | 6/17/2015 | Elect Director Cheryl L. Cohen | Issuer | Yes | For | For |
| Tokai Pharmaceuticals, Inc. | TKAI | 88907J107 | 6/17/2015 | Elect Director Joseph A. Yanchik, III | Issuer | Yes | For | For |
| Tokai Pharmaceuticals, Inc. | TKAI | 88907J107 | 6/17/2015 | Elect Director Jodie P. Morrison | Issuer | Yes | For | For |
| Tokai Pharmaceuticals, Inc. | TKAI | 88907J107 | 6/17/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Ultragenyx Pharmaceutical Inc. | RARE | 90400D108 | 6/9/2015 | Elect Director Michael Narachi | Issuer | Yes | For | For |
| Ultragenyx Pharmaceutical Inc. | RARE | 90400D108 | 6/9/2015 | Elect Director Clay B. Siegall | Issuer | Yes | For | For |
| Ultragenyx Pharmaceutical Inc. | RARE | 90400D108 | 6/9/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Versartis, Inc. | VSAR | 92529L102 | 5/21/2015 | Elect Director Edmon R. Jennings | Issuer | Yes | For | For |
| Versartis, Inc. | VSAR | 92529L102 | 5/21/2015 | Elect Director R. Scott Greer For For Management | Issuer | Yes | For | For |
| Versartis, Inc. | VSAR | 92529L102 | 5/21/2015 | Ratify PricewaterhouseCoopers LLP as Auditors | Issuer | Yes | For | For |
| Xenoport, Inc. | XNPT | 98411C100 | 5/19/2015 | Elect Director Dennis M. Fenton | Issuer | Yes | For | For |
| Xenoport, Inc. | XNPT | 98411C100 | 5/19/2015 | Elect Director Catherine J. Friedman | Issuer | Yes | For | For |
| Xenoport, Inc. | XNPT | 98411C100 | 5/19/2015 | Amend Omnibus Stock Plan | Issuer | Yes | For | For |
| Xenoport, Inc. | XNPT | 98411C100 | 5/19/2015 | Approve Qualified Employee Stock Purchase Plan | Issuer | Yes | For | For |
| Xenoport, Inc. | XNPT | 98411C100 | 5/19/2015 | Ratify Ernst & Young LLP as Auditors | Issuer | Yes | For | For |
| Xenoport, Inc. | XNPT | 98411C100 | 5/19/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| XOMA Corporation | XOMA | 98419J107 | 5/21/2015 | Elect Director John Varian | Issuer | Yes | For | For |
| XOMA Corporation | XOMA | 98419J107 | 5/21/2015 | Elect Director Patrick J. Scannon | Issuer | Yes | For | For |
| XOMA Corporation | XOMA | 98419J107 | 5/21/2015 | Elect Director W. Deman Van Ness | Issuer | Yes | For | For |
| XOMA Corporation | XOMA | 98419J107 | 5/21/2015 | Elect Director William K. Bowes, Jr. | Issuer | Yes | For | For |
| XOMA Corporation | XOMA | 98419J107 | 5/21/2015 | Elect Director Peter Barton Hatt | Issuer | Yes | For | For |
| XOMA Corporation | XOMA | 98419J107 | 5/21/2015 | Elect Director Joseph M. Limber | Issuer | Yes | For | For |
| XOMA Corporation | XOMA | 98419J107 | 5/21/2015 | Elect Director Timothy P. Walbert | Issuer | Yes | For | For |
| XOMA Corporation | XOMA | 98419J107 | 5/21/2015 | Elect Director Jack L. Wyszomierki | Issuer | Yes | For | For |
| XOMA Corporation | XOMA | 98419J107 | 5/21/2015 | Approve Qualified Employee Stock Purchase Plan | Issuer | Yes | For | For |
| ZIOPHARM Oncology, Inc. | ZIOP | 98973P101 | 6/9/2015 | Elect Director Jonathan Lewis | Issuer | Yes | For | For |
| ZIOPHARM Oncology, Inc. | ZIOP | 98973P101 | 6/9/2015 | Elect Director Murray Brennan | Issuer | Yes | For | For |
| ZIOPHARM Oncology, Inc. | ZIOP | 98973P101 | 6/9/2015 | Elect Director James A. Cannon | Issuer | Yes | For | For |
| ZIOPHARM Oncology, Inc. | ZIOP | 98973P101 | 6/9/2015 | Elect Director Wyche Fowler, Jr. | Issuer | Yes | For | For |
| ZIOPHARM Oncology, Inc. | ZIOP | 98973P101 | 6/9/2015 | Elect Director Randall Kirk | Issuer | Yes | For | For |
| ZIOPHARM Oncology, Inc. | ZIOP | 98973P101 | 6/9/2015 | Elect Director Michael Weiser | Issuer | Yes | For | For |
| ZIOPHARM Oncology, Inc. | ZIOP | 98973P101 | 6/9/2015 | Ratify McGladrey LLP as Auditors | Issuer | Yes | For | For |
| ZIOPHARM Oncology, Inc. | ZIOP | 98973P101 | 6/9/2015 | Advisory Vote to Ratify Named Executive Officers' Compensation | Issuer | Yes | For | For |
| ZS Pharma, Inc. | ZSPH | 98979G105 | 6/9/2015 | Elect Director Martin Babler | Issuer | Yes | For | For |
| ZS Pharma, Inc. | ZSPH | 98979G105 | 6/9/2015 | Elect Director Kim Popovits | Issuer | Yes | For | For |
| ZS Pharma, Inc. | ZSPH | 98979G105 | 6/9/2015 | Approve Qualified Employee Stock Purchase Plan | Issuer | Yes | For | For |
| ZS Pharma, Inc. | ZSPH | 98979G105 | 6/9/2015 | Ratify Ernst & Young, LLP as Auditors | Issuer | Yes | For | For |
SIGNATURES
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant ETFis Series Trust I
By (Signature and Title)* /s/ William Smalley
William Smalley, President
(Principal Executive Officer)
Date 9/9/2015
*Print the name and title of each signing officer under his or her signature.
